209 related articles for article (PubMed ID: 19670453)
1. Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.
Jayachandran J; Bañez LL; Aronson WJ; Terris MK; Presti JC; Amling CL; Kane CJ; Freedland SJ;
Cancer; 2009 Nov; 115(22):5263-71. PubMed ID: 19670453
[TBL] [Abstract][Full Text] [Related]
2. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.
Freedland SJ; Aronson WJ; Kane CJ; Presti JC; Amling CL; Elashoff D; Terris MK
J Clin Oncol; 2004 Feb; 22(3):446-53. PubMed ID: 14691122
[TBL] [Abstract][Full Text] [Related]
3. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
Hamilton RJ; Aronson WJ; Presti JC; Terris MK; Kane CJ; Amling CL; Freedland SJ
Cancer; 2007 Nov; 110(10):2202-9. PubMed ID: 17876838
[TBL] [Abstract][Full Text] [Related]
4. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.
Amling CL; Riffenburgh RH; Sun L; Moul JW; Lance RS; Kusuda L; Sexton WJ; Soderdahl DW; Donahue TF; Foley JP; Chung AK; McLeod DG
J Clin Oncol; 2004 Feb; 22(3):439-45. PubMed ID: 14691120
[TBL] [Abstract][Full Text] [Related]
5. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
[TBL] [Abstract][Full Text] [Related]
6. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Freedland SJ; Amling CL; Dorey F; Kane CJ; Presti JC; Terris MK; Aronson WJ;
Urology; 2002 Oct; 60(4):670-4. PubMed ID: 12385931
[TBL] [Abstract][Full Text] [Related]
7. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.
Freedland SJ; Jalkut M; Dorey F; Sutter ME; Aronson WJ
Urology; 2000 Jul; 56(1):87-91. PubMed ID: 10869631
[TBL] [Abstract][Full Text] [Related]
8. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
9. Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database.
Jayachandran J; Aronson WJ; Terris MK; Presti JC; Amling CL; Kane CJ; Freedland SJ
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):9-17. PubMed ID: 20056618
[TBL] [Abstract][Full Text] [Related]
10. The interaction of body mass index and race in predicting biochemical failure after radical prostatectomy.
Lee DJ; Ritch C; Desai M; Benson MC; McKiernan JM
BJU Int; 2011 Jun; 107(11):1741-7. PubMed ID: 20942835
[TBL] [Abstract][Full Text] [Related]
11. Effect of race and socioeconomic status on surgical margins and biochemical outcomes in an equal-access health care setting: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Chu DI; Moreira DM; Gerber L; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
Cancer; 2012 Oct; 118(20):4999-5007. PubMed ID: 22415377
[TBL] [Abstract][Full Text] [Related]
12. Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database.
Wu C; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2013 Jun; 111(8):E310-8. PubMed ID: 23305170
[TBL] [Abstract][Full Text] [Related]
13. Obesity, race, and long-term prostate cancer outcomes.
Vidal AC; Oyekunle T; Howard LE; De Hoedt AM; Kane CJ; Terris MK; Cooperberg MR; Amling CL; Klaassen Z; Freedland SJ; Aronson WJ
Cancer; 2020 Aug; 126(16):3733-3741. PubMed ID: 32497282
[TBL] [Abstract][Full Text] [Related]
14. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database.
Ho T; Gerber L; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
Eur Urol; 2012 Nov; 62(5):910-6. PubMed ID: 22921964
[TBL] [Abstract][Full Text] [Related]
15. Exposure to Agent Orange is a significant predictor of prostate-specific antigen (PSA)-based recurrence and a rapid PSA doubling time after radical prostatectomy.
Shah SR; Freedland SJ; Aronson WJ; Kane CJ; Presti JC; Amling CL; Terris MK
BJU Int; 2009 May; 103(9):1168-72. PubMed ID: 19298411
[TBL] [Abstract][Full Text] [Related]
16. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins.
Freedland SJ; Terris MK; Presti JC; Amling CL; Kane CJ; Trock B; Aronson WJ;
J Urol; 2004 Aug; 172(2):520-4. PubMed ID: 15247719
[TBL] [Abstract][Full Text] [Related]
17. Multivariate analysis of race and adverse pathologic findings after radical prostatectomy.
Freedland SJ; Dorey F; Aronson WJ
Urology; 2000 Nov; 56(5):807-11. PubMed ID: 11068307
[TBL] [Abstract][Full Text] [Related]
18. Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database.
Klaassen Z; Howard L; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Kane CJ; Freedland SJ
Cancer Epidemiol; 2015 Dec; 39(6):1066-70. PubMed ID: 26452418
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
20. Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy.
Aminsharifi A; Schulman A; Howard LE; Tay KJ; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ; Polascik TJ
Cancer; 2019 Sep; 125(17):3025-3032. PubMed ID: 31042315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
